Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$304K Buy
1,160
+9
+0.8% +$2.31K 0.03% 134
2026
Q2
$290K Buy
1,151
+21
+2% +$4.52K 0.03% 141
2026
Q1
$246K Sell
1,130
-110
-9% -$24.4K 0.03% 132
2025
Q4
$283K Buy
+1,240
New +$282K 0.03% 132

Other funds holding ABBV

LVZ Inc's ABBV Position: Q3 2026 in Review

LVZ Inc increased its AbbVie (ABBV) stake by 0.78% in Q3 2026, buying an estimated $2.31K and bringing the position to 1,160 shares worth $304K. The position accounts for 0.03% of the portfolio, ranked #134.

LVZ Inc first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • LVZ Inc held 1,160 shares of AbbVie worth $304K as of Q3 2026.
  • LVZ Inc bought 9 AbbVie shares in Q3 2026, an estimated $2.31K.
  • AbbVie made up 0.03% of LVZ Inc's portfolio in Q3 2026, its #134 holding.
  • LVZ Inc first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,097 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on LVZ Inc's 13F filing for Q3 2026, filed 20 Oct 2026.